中国肾脏移植受者微小病毒B19感染临床诊疗指南(2023版)  

Chinese guideline on the diagnosis and management of Human parvovirus B19 in Kidney transplantation(2023 edition)

作　　者：中华医学会器官移植学分会 金海龙 张庆 邱爽 刘杰[3] 范阳[3] 丁晨光[4] Branch of Organ Transplantation,Chinese Medical Association;Jin Hailong(不详;Department of Organ Transplantation,The Third Medical Center of the Chinese People's Liberation Army General Hospital,Beijing 100039,China)

机构地区：[1]不详 [2]中国人民解放军总医院第三医学中心,北京100089 [3]解放军总医院第三医学中心 [4]西安交通大学第一附属医院

出　　处：《中华器官移植杂志》2024年第4期199-215,共17页Chinese Journal of Organ Transplantation

摘　　要：人类微小病毒B19(human parvovirus B19,HPV-B19)感染可引起多种疾病,是导致肾脏移植术后纯红细胞再生障碍性贫血(pure red cell aplasia,PRCA)及移植肾脏等多器官病变的重要原因之一,并且其传染性可引发医院内传播感染。中华医学会器官移植学分会组织相关领域专家,从HPV-B19病原学、流行病学特点、临床表现、诊断、预防、治疗、存在的问题及展望等方面,依据循证推荐强度和证据分级,制订《中国肾脏移植受者微小病毒B19感染临床诊疗指南》,以期为我国肾脏移植术后HPV-B19感染的临床诊疗提供规范化指导。Human parvovirus B19(HPV-B19)infection may cause various diseases,including pure red cell aplastic anemia(PRCA),kidney injury and multiple organ lesions after kidney transplantation.And its infectivity causes nosocomial transmission.Branch of Organ Transplantation,Chinese Medical Association has convened the experts of different specialties to formulate the Chinese Guideline on the Diagnosis and Management of Human Parvovirus B19 in Kidney Transplantation"from the perspectives of HPV-B19 etiology,epidemiology,clinical manifestations,diagnosis,treatment and prevention.Evidence-based medicine was applied for further standardizing the diagnosis,treatment and prevention of HPV-B19 infection in kidney transplant recipients.

关 键 词：肾脏移植 微小病毒B19 诊断 治疗 

分 类 号：R699.2[医药卫生—泌尿科学] R511[医药卫生—外科学]